C49.A2 Gastrointestinal stromal tumor of stomach

Name of the Condition

• Gastrointestinal stromal tumor of stomach
• ICD-10 Code: C49.A2

Summary

Gastrointestinal stromal tumor (GIST) of the stomach is a type of cancer originating in the stomach. These tumors arise from interstitial cells of Cajal and are classified as soft tissue sarcomas. GISTs can vary in behavior, with some being benign and others malignant, and their treatment depends on factors like size, location, and genetic characteristics. The stomach site specifies the tumor's location within the gastrointestinal tract.

Causes

The exact cause of GISTs is not fully understood, but most cases are associated with mutations in the KIT or PDGFRA genes. These mutations lead to uncontrolled cell growth in the GI tract. While most GISTs occur sporadically, a small number may be linked to inherited genetic syndromes, though this is rare.

Risk Factors

• Age (more common in older adults)
• Gender (slightly more prevalent in males)
• Prior radiation exposure to the abdomen
• Certain genetic syndromes (e.g., neurofibromatosis type 1)

Symptoms

• Abdominal pain or discomfort
• Nausea or vomiting
• Blood in stool or black, tarry stools
• Feeling full after eating small amounts
• Unexplained weight loss
• Abdominal mass or swelling

Diagnosis

Diagnosis typically involves imaging tests such as CT scans, MRI, or endoscopic ultrasound to locate the tumor. A biopsy is often performed to confirm the diagnosis and assess the tumor's genetic characteristics, which guide treatment decisions.

Treatment Options

Treatment depends on tumor size, location, and genetic profile. Options may include surgery to remove the tumor, targeted therapy with tyrosine kinase inhibitors (e.g., imatinib), and in some cases, chemotherapy or radiation. Clinical trials may be available for advanced or resistant cases.

Prognosis and Follow-Up

Prognosis varies based on tumor size, mitotic rate, and genetic features. Regular follow-up with imaging and clinical evaluations is recommended to monitor for recurrence or progression. Long-term survival is possible with appropriate treatment, especially for localized tumors.

Complications

Potential complications include tumor rupture, bleeding, obstruction of the stomach or intestines, and metastasis to other organs (e.g., liver, peritoneum). Advanced or untreated tumors may lead to significant morbidity.

Lifestyle & Prevention

No specific lifestyle changes prevent GIST, but maintaining overall health may support treatment outcomes. Avoiding known risk factors, such as unnecessary radiation exposure, is advisable. Genetic counseling may be considered for those with a family history of GIST or related syndromes.

When to Seek Professional Help

Seek medical attention for persistent abdominal pain, unexplained weight loss, blood in stool, or other concerning symptoms. Early evaluation is important for timely diagnosis and management.

Tips for Medical Coders

Code C49.A2 is specific to gastrointestinal stromal tumors of the stomach. Documentation should specify the tumor's location and confirm the diagnosis (e.g., biopsy results, imaging). Ensure the code aligns with the patient's clinical findings and avoid using this code for tumors at other GI sites.